U
XTL Biopharmaceuticals Ltd. XTLB
$2.60 -$0.16-5.80%
Recommendation
--
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2022 09/30/2022 06/30/2022 03/31/2022 12/31/2021
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses -15.08% -5.69% -5.48% 16.89% 10.00%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -14.65% -6.09% -6.14% 13.54% 8.76%
Operating Income 14.65% 6.09% 6.14% -13.54% -8.76%
Income Before Tax -409.17% 141.23% 152.70% 123.09% 114.76%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -409.17% 141.23% 152.70% 123.09% 114.76%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -409.17% 141.23% 152.70% 123.09% 114.76%
EBIT 14.65% 6.09% 6.14% -13.54% -8.76%
EBITDA 14.66% 6.09% -19.56% -48.52% -117.66%
EPS Basic -516.67% 138.57% 148.21% 118.18% 110.53%
Normalized Basic EPS -91.67% 166.67% 166.67% 130.00% 130.00%
EPS Diluted -212.50% 117.81% 122.03% 93.10% 86.67%
Normalized Diluted EPS -66.67% 145.24% 145.24% 107.50% 107.50%
Average Basic Shares Outstanding 1.97% 3.43% 4.27% 4.12% 3.92%
Average Diluted Shares Outstanding -11.82% 19.29% 20.31% 20.27% 20.17%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings